estriol has been researched along with tibolone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campanini, D; Facchinetti, F; Genazzani, AR; Grasso, A; Petraglia, F; Volpe, A | 1 |
Hammar, M; Nathorst-Böös, J | 1 |
Coelingh Bennink, HJ; Dören, M; Holzgreve, W; Rübig, A | 1 |
Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F | 1 |
Bakken, K; Lund, E; Sæther, S | 1 |
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
1 review(s) available for estriol and tibolone
Article | Year |
---|---|
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
3 trial(s) available for estriol and tibolone
Article | Year |
---|---|
Benefits and risks of different hormonal replacement therapies in post-menopausal women.
Topics: Adult; Cholesterol; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Endometrium; Estradiol; Estriol; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norpregnenes | 1986 |
Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen.
Topics: Anabolic Agents; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Libido; Middle Aged; Norethindrone; Norpregnenes; Sexual Behavior | 1997 |
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Topics: Aged; Anabolic Agents; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endosonography; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Norpregnenes; Prospective Studies; Tablets; Uterine Hemorrhage; Vagina | 1999 |
2 other study(ies) available for estriol and tibolone
Article | Year |
---|---|
Mammographic density changes during different postmenopausal hormone replacement therapies.
Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors | 2001 |
The risk of breast cancer linked to menopausal hormone therapy.
Topics: Breast Neoplasms; Case-Control Studies; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Odds Ratio; Postmenopause; Progestins; Prospective Studies; Risk Factors; Surveys and Questionnaires | 2012 |